arrow
Back
S

Sarah Lonergan

Erasmus University Rotterdam

12H-index
29Paper Count
941Citation Count
Published Papers 4
Publication Date
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myeloma
err2024-09-17
err0
errOAAI
errSonneveld, Pieter; Dimopoulos, Meletios A.; Boccadoro, Mario; Quach, Hang; Ho, P. Joy; Beksac, Meral; Hulin, Cyrille; Antonioli, Elisabetta; Leleu, Xavier; Mangiacavalli, Silvia; Perrot, Aurore; Cavo, Michele; Belotti, Angelo; Broijl, Annemiek; Gay, Francesca; Mina, Roberto; van de Donk, Niels W. C. J.; Katodritou, Eirini; Schjesvold, Fredrik; Balari, Anna Sureda; Rosinol, Laura; Delforge, Michel; Roeloffzen, Wilfried; Silzle, Tobias; Vangsted, Annette; Einsele, Hermann; Spencer, Andrew; Hajek, Roman; Jurczyszyn, Artur; Lonergan, Sarah; Ahmadi, Tahamtan; Liu, Yanfang; Wang, Jianping; Vieyra, Diego; van Brummelen, Emilie M. J.; Vanquickelberghe, Veronique; Sitthi-Amorn, Anna; de Boer, Carla J.; Carson, Robin; Rodriguez-Otero, Paula; Blade, Joan; Moreau, Philippe
errShare
errSave
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
err2024-01-25
err106
errOAAI
errSonneveld, Pieter; Dimopoulos, Meletios A.; Boccadoro, Mario; Quach, Hang; Ho, P. Joy; Beksac, Meral; Hulin, Cyrille; Antonioli, Elisabetta; Leleu, Xavier; Mangiacavalli, Silvia; Perrot, Aurore; Cavo, Michele; Belotti, Angelo; Broijl, Annemiek; Gay, Francesca; Mina, Roberto; Nijhof, Inger S.; van de Donk, Niels W. C. J.; Katodritou, Eirini; Schjesvold, Fredrik; Sureda Balari, Anna; Rosinol, Laura; Delforge, Michel; Roeloffzen, Wilfried; Silzle, Tobias; Vangsted, Annette; Einsele, Hermann; Spencer, Andrew; Hajek, Roman; Jurczyszyn, Artur; Lonergan, Sarah; Ahmadi, Tahamtan; Liu, Yanfang; Wang, Jianping; Vieyra, Diego; van Brummelen, Emilie M. J.; Vanquickelberghe, Veronique; Sitthi-Amorn, Anna; de Boer, Carla J.; Carson, Robin; Rodriguez-Otero, Paula; Blade, Joan; Moreau, Philippe
errShare
errSave
Carfilzomib Combined With Thalidomide and Low-dose Dexamethasone for Remission Induction and Consolidation in Newly Diagnosed Transplant Eligible Patients With Multiple Myeloma: 8 vs 4 Induction Cycles; the Carthadex Trial
err2020-08-12
err0
errOAAI
errWester, Ruth; Zweegman, Sonja; van der Holt, Bronno; Kersten, Marie Jose; Vellenga, Edo; van Marwijk-Kooy, Marinus; Asselbergs, Emelie; de Weerdt, Okke; Minnema, Monique C.; Lonergan, Sarah; Palumbo, Antonio; Broijl, Annemiek; Sonneveld, Pieter
errShare
errSave
Phase II study of carfilzomib, thalidomide, and low-dose dexamethasone as induction and consolidation in newly diagnosed, transplant eligible patients with multiple myeloma; the Carthadex trial
err2019-04-04
err16
errOAAI
errWester, Ruth; van der Holt, Bronno; Asselbergs, Emelie; Zweegman, Sonja; Kersten, Marie Jose; Vellenga, Edo; Kooy, Marinus van Marwijk; de Weerdt, Okke; Minnema, Monique; Lonergan, Sarah; Palumbo, Antonio; Lokhorst, Henk; Broijl, Annemiek; Sonneveld, Pieter
errShare
errSave